Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Mucosal Immunol ; 8(2): 232-42, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24985083

ABSTRACT

The integrity of the intestinal epithelium is constantly surveyed by a peculiar subset of innate-like T lymphocytes embedded in the epithelial cell layer, hence called intestinal intraepithelial lymphocytes (IELs). IELs are thought to act as "first-line" sentinels sensing the state of adjacent epithelial cells via both T-cell receptors and auxiliary receptors. Auxiliary receptors modulating IEL activity include C-type lectin-like receptors encoded in the natural killer gene complex such as NKG2D. Here, we report that the CTLR Nkrp1g is expressed by a subpopulation of mouse CD103(+) IELs allowing immunosensing of the intestinal epithelium through ligation of the genetically coupled CTLR Clr-f that is almost exclusively expressed on differentiated intestinal epithelial cells (IECs). Most of these Nkrp1g-expressing IELs exhibit a γδTCR(bright)Nkg2a(-) phenotype and are intimately associated with the intestinal epithelium. As Clr-f expression strongly inhibits effector functions of Nkrp1g-expressing cells and is upregulated upon poly(I:C) challenge, Clr-f molecules may quench reactivity of these IELs towards the epithelial barrier that is constantly provoked by microbial and antigenic stimuli. Altogether, we here newly characterize a genetically linked C-type lectin-like receptor/ligand pair with a highly restricted tissue expression that apparently evolved to allow for a dedicated immunosurveillance of the mouse intestinal epithelium.


Subject(s)
Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Lectins, C-Type/genetics , Animals , Cell Line , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Gene Expression , Humans , Immunophenotyping , Intestinal Mucosa/drug effects , Lectins, C-Type/chemistry , Lectins, C-Type/metabolism , Lymphocytes/immunology , Lymphocytes/metabolism , Mice , Multigene Family , NK Cell Lectin-Like Receptor Subfamily B/genetics , NK Cell Lectin-Like Receptor Subfamily B/metabolism , Organ Specificity/genetics , Peyer's Patches/cytology , Peyer's Patches/immunology , Peyer's Patches/metabolism , Phenotype , Poly I-C/pharmacology , Protein Binding , Protein Multimerization , Receptors, Antigen, T-Cell/metabolism , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism
2.
Scand J Immunol ; 76(5): 464-70, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22803811

ABSTRACT

Mesenchymal stromal cells (MSC) can be used to treat graft-versus-host disease (GVHD) caused by allogeneic stem cell transplantation (allo-SCT). The effectiveness of this therapy has been variable in clinical trials and in experimental animal models. In this study, we investigated the ability of bone marrow (BM)-derived MSC to alleviate GVHD in an experimental rat model of allo-SCT using two different combinations of major histocompatibility complex (MHC) mismatch with survival as the primary endpoint. Recipient rats received total body irradiation and a transplant of T cell-depleted donor BM cells with either a full [PVG.7B → BN] or a partial MHC mismatch [PVG.1U → PVG.R23] restricted to the class II and non-classical class I sub-regions (RT1-B/D-CE/N/M). GVHD was invoked by infusion of graded doses of donor leukocytes 2 weeks after allo-SCT. Weekly doses of MSC were injected starting on the day of donor leukocyte infusion. No significant overall improvement of mortality and morbidity was observed in the two transplantation settings. Stimulation of MSC with exogenous tumor necrosis factor α and interferon (IFN)γ prior to infusion could not rescue BM-transplanted rats from lethal acute GVHD. In conclusion, repeated administrations of MSC failed to alleviate GVHD after fully or partially MHC-mismatched allo-SCT in the rat.


Subject(s)
Bone Marrow Transplantation , Graft vs Host Disease/therapy , Major Histocompatibility Complex/immunology , Mesenchymal Stem Cell Transplantation , Acute Disease , Animals , Female , Histocompatibility Testing , Male , Nitric Oxide/physiology , Rats
3.
Tissue Antigens ; 78(2): 81-8, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21726202

ABSTRACT

NK cells are important contributors to the early immune defence against infected or transformed cells. They are rapidly activated in response to cytokines, whereby they exert their effector functions. NK cell responses are controlled by a multitude of receptors, which are expressed by subpopulations of NK cells with distinct phenotypes and functionalities. Direct comparisons between species are often difficult because of differences in the expression of NK cell receptors and other markers. In addition, NK cells change their phenotype and effector functions during differentiation, by tissue-specific factors, or upon activation, complicating interpretations. We will here review the similarities and differences between the major NK cell subsets in man and two well-characterized rodent models.


Subject(s)
Killer Cells, Natural/cytology , Animals , CD56 Antigen/biosynthesis , Cell Adhesion Molecules/metabolism , Cell Differentiation , Histocompatibility Antigens Class I/metabolism , Humans , Inflammation , Killer Cells, Natural/metabolism , Mice , Phenotype , Protein Binding , Rats
5.
Scand J Immunol ; 54(4): 341-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11555400

ABSTRACT

We have depleted lymphocyte subsets in PVG and AO rats with MoAbs 3.2.3 (against NKR-P1 on NK and NK/T cells) and OX-8 (against CD8 on CTL and NK cells), and examined the effect on the killing of YAC-1 target cells in vitro and the effect on the acute rejection of small allogeneic lymphocytes in vivo (allogeneic lymphocyte cytotoxicity, ALC). While 3.2.3 treatment led to only a partial depletion of 3.2.3-positive cells in PVG rats, this treatment drastically reduced the number of NKR-P1+ cells in AO rats, abolished splenic NK activity against the NK-sensitive tumour target YAC-1, and markedly diminished the ALC response. Rats treated with OX-8 for 1 day showed a similar loss of NK cell function in vivo and in vitro. However, in rats treated with OX-8 for 3 days a 3.2.3+ and OX-8- population consisting of NK cells appeared, restoring ALC. The results demonstrate that NK cell responses can be greatly diminished after in vivo treatment with these MoAbs. Furthermore, they demonstrate that ALC is not necessarily linked to expression of the CD8 molecule.


Subject(s)
Antigens, Surface/immunology , CD8 Antigens/immunology , Graft Rejection/immunology , Killer Cells, Natural/immunology , Lectins, C-Type , T-Lymphocytes, Cytotoxic/immunology , Animals , Antibodies, Monoclonal/immunology , Lymphocyte Depletion , Mice , NK Cell Lectin-Like Receptor Subfamily B , Rats , Transplantation, Homologous , Tumor Cells, Cultured
6.
Immunol Rev ; 181: 149-57, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11513136

ABSTRACT

Rat natural killer (NK) cells recognize MHC-I molecules encoded by both the classical (RT1-A) and non-classical (RT1-C/E/M) MHC class I (MHC-I) regions. We have identified a receptor, the STOK2 antigen, which belongs to the Ly-49 family of killer cell lectin-like receptors, and we have localized the gene encoding it to the rat natural killer cell gene complex. We have also shown that it inhibits NK cytotoxicity when recognizing its cognate MHC-I ligand RT1-A1c on a target cell. This is the first inhibitory Ly-49-MHC-I interaction identified in the rat and highlights the great similarity between rat and mouse Ly-49 receptors and their MHC ligands. However, the mode of rat NK-cell recognition of target cells indicates that positive recognition of allo-MHC determinants, especially those encoded by the RT1-C/E/M region, is a prevalent feature. NK cells recruited to the peritoneum as a consequence of alloimmunization display positive recognition of allodeterminants. In one case, NK cells activated in this way have been shown to be specific for the immunizing, non-classical class I molecule RT1-Eu. These findings show that allospecific NK cells sometimes show features reminiscent of the adaptive immune response.


Subject(s)
Antigens, Ly , Histocompatibility Antigens Class I/metabolism , Killer Cells, Natural/immunology , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolism , Animals , Histocompatibility Antigens/genetics , Histocompatibility Antigens/metabolism , Isoantigens/genetics , Isoantigens/metabolism , Lectins, C-Type , Ligands , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Multigene Family , Rats , Receptors, Mitogen/genetics , Receptors, Mitogen/metabolism , Receptors, NK Cell Lectin-Like , T-Lymphocytes/immunology
7.
Cell Signal ; 13(3): 213-20, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11282460

ABSTRACT

The type III transmembrane adaptor protein linker for activation of T cells (LAT) is essential for membrane recruitment of signalling molecules following TCR activation. Here we show that although LAT deleted in the transmembrane domain is completely soluble, it can be tyrosine phosphorylated after anti-CD3 stimulation or pervanadate treatment. Overexpression of this deletion mutant in transiently transfected Jurkat TAg cells inhibits transcriptional activation of nuclear factor of activated T cells (NF-AT)/AP-1 reporter construct in a concentration-dependent manner. Furthermore, by selection of transiently transfected cells, a clear reduction of TCR-induced CD69 expression was observed in cells expressing the mutant. These dominant negative effects seemed to be dependent both on the ability of the membrane deletion mutant to reduce phosphorylation of endogenous LAT and to reduce interaction of endogenous LAT with PLC-gamma1 and Grb2. Consistent with this, the redistribution of PLC-gamma1 and Grb2 to glycolipid-enriched microdomains, called lipid rafts, after stimulation was inhibited when the soluble form of LAT was overexpressed. We suggest that the dominant negative effect is caused by the ability of the mutant to sequester signalling molecules in cytosol and thereby inhibit redistribution of signalling molecules to lipid rafts upon T-cell activation.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/genetics , Carrier Proteins/metabolism , Gene Deletion , Glycolipids/chemistry , Lymphocyte Activation/genetics , Phosphoproteins/genetics , T-Lymphocytes/metabolism , Tyrosine/metabolism , Carrier Proteins/analysis , Electroporation , Humans , In Vitro Techniques , Isoenzymes/metabolism , Jurkat Cells , Membrane Proteins/metabolism , Mutagenesis , Phosphorylation , Protein Binding , Protein Processing, Post-Translational , Protein Structure, Tertiary , Protein-Tyrosine Kinases/metabolism , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , Transcription Factors/genetics , Transcription Factors/metabolism , Type C Phospholipases/metabolism , Tyrosine/chemistry
8.
Eur J Immunol ; 30(12): 3355-62, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11093152

ABSTRACT

Here we report the generation of monoclonal antibodies (mAb) LOV3 and LOV8 to a 110-130-kDa membrane glycoprotein expressed by rat NK cells. This NK surface molecule was identified by eucaryotic expression cloning as the structural orthologue of the phagocytosis-stimulating receptor for complement factor C1q and mannose-binding lectin on human macrophages, C1qRp. Rat C1qRp is a monomeric type I integral membrane protein consisting of 643 amino acids with an N-terminal lectin-like domain, five epidermal growth factor-like domains, a transmembrane domain and a 45-residue cytoplasmic domain. It is encoded by a single gene on rat chromosome 3q41-q42 and is 67% and 87.5% identical at the amino acid level to human and mouse C1qRp, respectively. Rat C1qRp is expressed by resting and by activated NK cells, on subpopulations of NKR-P1(+) T cells (NK/T cells), dendritic cells, macrophages and granulocytes, but not by B cells or NKR-P1(-) T cells. Expression of this innate immune receptor is therefore not restricted to hematopoietic cells of the myeloid lineage, but is also expressed on subsets of cells of lymphoid origin. The mAb did not affect the cytotoxic function of NK cells, and C1qRp on NK cells may have functions not related to NK killing.


Subject(s)
Hyaluronan Receptors , Killer Cells, Natural/chemistry , Membrane Glycoproteins , Receptors, Cell Surface/genetics , Receptors, Complement/genetics , Amino Acid Sequence , Animals , Carrier Proteins , Chromosome Mapping , Cloning, Molecular , Humans , Mice , Mice, Inbred BALB C , Mitochondrial Proteins , Molecular Sequence Data , Rats , Receptors, Complement/analysis , Receptors, Complement/chemistry
9.
Eur J Immunol ; 29(6): 2046-53, 1999 06.
Article in English | MEDLINE | ID: mdl-10382768

ABSTRACT

We have generated a monoclonal antibody (STOK2) which reacts with an inhibitory MHC receptor on a subset of alloreactive NK cells in the rat. This receptor, termed the STOK2 antigen (Ag), belongs to the Ly-49 family of lectin-like molecules and displays specificity for the classical MHC class I molecule RT1-A1c of PVG rats. Here, we have investigated the influence of the MHC on the selection, phenotype and function of the STOK2+ NK subset in a panel of MHC congenic and intra-MHC recombinant strains. STOK2 receptor density was influenced by the presence of its classical MHC I ligand RT1-A1c, as evidenced by a reduction of STOK2 Ag on the surface of NK cells from RT1-A1c+, as compared with RT1-A1c-, strains. In addition, a role for nonclassical MHC I RT1-C/E/M alleles in the selection of the STOK2 Ag was demonstrated. The relative number of STOK2+ NK cells was fivefold higher in rats expressing the RT1-C/E/M(av1) as compared with those expressing the RT1-C/E/M(u) class Ib haplotype. The STOK2 ligand RT1-A1c inhibited cytotoxicity of STOK2+ NK cells regardless of effector cell MHC haplotype. Allospecificity of STOK2+ NK cells varied markedly with effector cell MHC, however, and suggested that inhibitory MHC I receptors apart from STOK2 were variably co-expressed by these cells. These data provide evidence for the MHC-dependent regulation of the allospecific repertoire within a subset of potentially autoreactive Ly-49+ rat NK cells.


Subject(s)
Antigens, Ly , Genes, MHC Class I , Killer Cells, Natural/classification , Killer Cells, Natural/immunology , Membrane Glycoproteins/immunology , Alleles , Animals , Animals, Congenic , Antibodies, Monoclonal , Autoimmunity , Cytotoxicity, Immunologic , Female , Histocompatibility Antigens/metabolism , In Vitro Techniques , Lectins, C-Type , Male , Phenotype , Rats , Receptors, NK Cell Lectin-Like
10.
J Immunol ; 162(5): 2683-92, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10072512

ABSTRACT

Previous studies in humans and mice have shown that gut intraepithelial lymphocytes (IELs) express oligoclonal TCR beta-chain repertoires. These studies have either employed unseparated IEL preparations or focused on the CD8+ subsets. Here, we have analyzed the TCR beta-chain repertoire of small intestinal IELs in PVG rats, in sorted CD4+ as well as CD8+ subpopulations, and important differences were noted. CD8alphaalpha and CD8alphabeta single-positive (SP) IELs used most Vbeta genes, but relative Vbeta usage as determined by quantitative PCR analysis differed markedly between the two subsets and among individual rats. By contrast, CD4+ IELs showed consistent skewing toward Vbeta17 and Vbeta19; these two genes accounted collectively for more than half the Vbeta repertoire in the CD4/CD8 double-positive (DP) subset and were likewise predominant in CD4 SP IELs. Complementarity-determining region 3 length displays and TCR sequencing demonstrated oligoclonal expansions in both the CD4+ and CD8+ IEL subpopulations. These studies also revealed that the CD4 SP and CD4/CD8 DP IEL subsets expressed overlapping beta-chain repertoires. In conclusion, our results show that rat TCR-alphabeta+ IELs of both the CD8+ and CD4+ subpopulations are oligoclonal. The limited Vbeta usage and overlapping TCR repertoire expressed by CD4 SP and CD4/CD8 DP cells suggest that these two IEL populations recognize restricted intestinal ligands and are developmentally and functionally related.


Subject(s)
CD4 Antigens/analysis , CD8 Antigens/analysis , Intestinal Mucosa/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocyte Subsets/immunology , Animals , Female , Rats
11.
J Immunol ; 162(2): 743-52, 1999 Jan 15.
Article in English | MEDLINE | ID: mdl-9916694

ABSTRACT

In common with other mammalian species, the laboratory rat (Rattus norvegicus) expresses MHC class I molecules that have been categorized as either classical (class Ia) or nonclassical (class Ib). This distinction separates the class Ia molecules that play a conventional role in peptide Ag presentation to CD8 T cells from the others, whose function is unconventional or undefined. The class Ia molecules are encoded by the RT1-A region of the rat MHC, while the RT1-C/E/M region encodes up to 60 other class I genes or gene fragments, a number of which are known to be expressed (or to be expressible). Here we report upon novel MHC class Ib genes of the rat that we have expression cloned using new monoclonal alloantibodies and which we term RT1-U. The products detected by these Abs were readily identifiable by two-dimensional analysis of immunoprecipitates and were shown to be distinct from the class Ia products. Cellular studies of these molecules indicate that they function efficiently as targets for cytotoxic killing by appropriately raised polyclonal alloreactive CTL populations. The sequences of these class Ib genes group together in phylogenetic analysis, suggesting a unique locus or family. The combined serological, CTL, and sequence data all indicate that these products are genetically polymorphic.


Subject(s)
Histocompatibility Antigens/genetics , Histocompatibility Antigens/isolation & purification , Amino Acid Sequence , Animals , Antibodies, Monoclonal/metabolism , Antigen Presentation , Antigen-Antibody Reactions , Base Sequence , Cloning, Molecular , DNA, Complementary/isolation & purification , Female , Haplotypes , Histocompatibility Antigens/immunology , Histocompatibility Antigens/metabolism , L Cells , Mice , Molecular Sequence Data , Multigene Family/immunology , Polymorphism, Genetic , Precipitin Tests , Rats , Rats, Inbred Strains , Sequence Homology, Nucleic Acid , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
12.
J Exp Med ; 187(7): 1157-61, 1998 Apr 06.
Article in English | MEDLINE | ID: mdl-9529333

ABSTRACT

Activation of T and natural killer (NK) cells leads to the tyrosine phosphorylation of pp36 and to its association with several signaling molecules, including phospholipase Cgamma-1 and Grb2. Microsequencing of peptides derived from purified rat pp36 protein led to the cloning, in rat and man, of cDNA encoding a T- and NK cell-specific protein with several putative Src homology 2 domain-binding motifs. A rabbit antiserum directed against a peptide sequence from the cloned rat molecule recognized tyrosine phosphorylated pp36 from pervanadate-treated rat thymocytes. When expressed in 293T human fibroblast cells and tyrosine-phosphorylated, pp36 associated with phospholipase Cgamma-1 and Grb2. Studies with GST-Grb2 fusion proteins demonstrated that the association was specific for the Src homology 2 domain of Grb-2. Molecular cloning of the gene encoding pp36 should facilitate studies examining the role of this adaptor protein in proximal signaling events during T and NK cell activation.


Subject(s)
Adaptor Proteins, Signal Transducing , Deoxyuridine/analogs & derivatives , Killer Cells, Natural/immunology , Propanolamines/chemistry , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Cells, Cultured , Cloning, Molecular , Deoxyuridine/chemistry , GRB2 Adaptor Protein , Humans , Isoenzymes/metabolism , Molecular Sequence Data , Peptide Fragments/immunology , Phospholipase C gamma , Phosphoproteins/chemistry , Proteins/metabolism , RNA, Messenger/metabolism , Rats , Recombinant Proteins/immunology , Sequence Analysis, DNA , Thymus Gland/physiology , Type C Phospholipases/metabolism , src Homology Domains/genetics
13.
J Immunol ; 160(1): 219-24, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9551974

ABSTRACT

Studies of allogeneic lymphocyte cytotoxicity have shown that the rat NK allorecognition repertoire is controlled by genetic elements in both the MHC (RT1) and the NK gene complex (NKC). DA rats, possessing NK cells that are unable to lyse allogeneic lymphoblasts, were immunized with alloreactive NK cells from MHC-matched PVG.1AV1 rats, and two mAb, STOK1 and STOK2, were generated. STOK1 and STOK2 stained identical subsets of NKR-P1+ T and NK cells from certain strains of rats. Relative numbers varied markedly in a panel of MHC congenic strains, however, implicating a role for self MHC genes in their development. Both STOK1 and STOK2 immunoprecipitated a 110-kDa disulfide-linked homodimeric molecule, with extensive N-linked glycosylations, encoded by a gene that mapped to the NKC. NK cells expressing this glycoprotein displayed an increased ability to lyse allogeneic lymphoblasts, while syngeneic targets were spared. However, blockade of the STOK2 Ag with F(ab')2 of STOK2 permitted the NK lysis of syngeneic targets, but did not affect NK allorecognition. These results indicate that mAb STOK1 and STOK2 identify an NKC-encoded MHC receptor in the rat that acts as a negative regulator of cytotoxicity.


Subject(s)
Histocompatibility Antigens/immunology , Killer Cells, Natural/immunology , Major Histocompatibility Complex , Receptors, Immunologic/immunology , Animals , Antibodies, Monoclonal , Autoantigens/immunology , Cell Membrane/immunology , Cytotoxicity, Immunologic , Isoantigens/immunology , Lymphocyte Subsets/immunology , Membrane Proteins/immunology , Rats , Rats, Inbred Strains
14.
Transplantation ; 65(3): 319-24, 1998 Feb 15.
Article in English | MEDLINE | ID: mdl-9484746

ABSTRACT

BACKGROUND: We have studied the role of the different MHC (RT1) subregions in acute natural killer (NK) cell-mediated bone marrow allograft rejection in lethally irradiated, bone marrow cell (BMC) reconstituted rats. METHODS: We employed a series of MHC congenic and intra-MHC recombinant rat strains so that effects of mismatches in defined RT1 subregions could be studied systematically. BMC allograft survival was measured as 125IUdR uptake in the spleen between day 5 and day 7 after irradiation and BMC reconstitution. RESULTS: We found that in certain RT1 haplotype combinations, nonclassical RT1.C disparities by themselves could determine graft rejection (i.e., in the u/av1 recombinant haplotypes), whereas in another combination (between the av1 and c haplotypes) a mismatch for an isolated classical RT1.A region was decisive for engraftment. Thus, PVG.R1 BMC failed to proliferate in PVG rats, differing in the RT1.A region only, whereas in PVG.1U rats rejection could be determined by isolated differences in the RT1.C region (LEW.1WR1). Also, RT1 homozygous rats (RT1.U) rejected semi-allogeneic F1 hybrid BMC. The acute rejection of BMC was mediated by NK cells, as athymic nude rats, lacking alloreactive T cells but with normal alloreactive NK cells, showed the same patterns of rejection as did normal rats. Nude rats also rejected allogeneic lymphocytes, a previously documented NK-mediated phenomenon, with identical requirements of MHC disparity. CONCLUSIONS: This investigation shows that rat effector NK cells are radioresistant, independent of the thymus, and capable of recognizing and rejecting MHC mismatched transplanted BMC on the basis of mismatches in both classical and nonclassical class I regions in vivo. The studies underline the importance also of NK cells in determining BMC allograft survival.


Subject(s)
Bone Marrow Transplantation/immunology , Graft Rejection/immunology , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens/immunology , Killer Cells, Natural/immunology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/pathology , Bone Marrow Transplantation/pathology , Graft Survival/immunology , Idoxuridine/pharmacokinetics , Iodine Radioisotopes/pharmacokinetics , Mice , Mice, Inbred Strains , Rats , Rats, Inbred Lew , Rats, Nude , Time Factors , Transplantation, Homologous , Transplantation, Isogeneic
15.
Scand J Immunol ; 46(4): 349-57, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9350285

ABSTRACT

Recent studies in mice and humans have provided evidence for regional specialization of gut intraepithelial lymphocytes (IEL). Here the authors report striking regional variability in the composition of IEL in rat small and large intestine. Two-colour immunofluorescence in situ analysis showed that the distribution of the CD3+ and CD3- IEL subpopulations varied, the proportion of T cells (CD3+) being higher in the ileum than in the jejunum and smallest in the colon. These differences were explained by variable numbers of the T-cell receptor (TCR)alpha/beta + (both CD8+ and CD4+) but not the TCR gamma/delta + subset. Moreover, the various IEL subpopulations showed distinct intraepithelial distribution patterns with CD4+ and CD8 alpha beta + T cells situated near the lamina propria, while CD3- IEL were located preferentially towards the adluminal part of the epithelium. Regional phenotypic variation did not depend on intestinal colonization because analogous results were obtained in germ-free rats. Conventionalization nevertheless caused a marked relative increase of small intestinal TCR alpha/beta + but not TCR gamma/delta + IEL. This increase was more sustained in the jejunum than ileum and eventually reduced the phenotypic IEL differences between the two sites. By contrast, microbial colonization of the colon induced only a transient increase of intraepithelial TCR alpha/beta + cells with no permanent phenotypic alterations. Both CD3+ and CD3- IEL contained subpopulations that expressed NKR-P1 independent of intestinal colonization. These results demonstrate phenotypic specialization of IEL at different levels of the gut and suggest that the indigenous flora is not essential to this end.


Subject(s)
Epithelial Cells/immunology , Intestine, Small/immunology , Intestine, Small/microbiology , Lectins, C-Type , Lymphocyte Subsets/classification , Animals , Antigens, Surface/biosynthesis , CD3 Complex/metabolism , Epithelial Cells/classification , Epithelium/immunology , Epithelium/microbiology , Germ-Free Life , Ileum/cytology , Ileum/immunology , Ileum/microbiology , Immunophenotyping , Intestine, Small/cytology , Jejunum/cytology , Jejunum/immunology , Jejunum/microbiology , Killer Cells, Natural/metabolism , Lymphocyte Subsets/metabolism , NK Cell Lectin-Like Receptor Subfamily B , Rats , Rats, Inbred Lew , Receptors, Immunologic/biosynthesis
16.
Int Immunol ; 9(7): 1043-51, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9237113

ABSTRACT

We have successfully cloned nine NKR-P1+ TCR alpha beta + cells from PVG rat spleens, utilizing murine macrophage inflammatory protein-1 alpha (MIP-1 alpha) and IL-2. These clones are either double negative (DN, CD4-CD8-), which included clones 3.31, 3.71, 4.19, 4.59 and 4.65, or single positive (SP, CD4+CD8-), which included clones 1.64, 3.8, 3.76 and 3.78. No CD8+ clone was recovered. All nine clones are restricted in terms of their expression of the V beta antigens, since they express V beta 8.2 but not V beta 8.5, V beta 10 or V beta 16. These clones are agranular and they fall to generate NK or LAK activity upon incubation with IL-2, IL-12 or their combination. On the basis of their production of intracellular cytokines they can be divided into three categories: (I) SP clones (1.64, 3.8, 3.76 and 3.78) do not produce IL-2 or IL-4, but produce IFN-gamma and IL-12, and they vary in their production of IL-1, RANTES or tumor necrosis factor (TNF)-alpha; (II) DN clones 4.59 and 4.65 produce IL-1 alpha and IFN-gamma only, and fall to produce other cytokines; and (III) DN clones 3.31, 3.71 and 4.19 produce IL-1 alpha, IL-1 beta, IL-2, IL-12, IFN-gamma, RANTES and TNF-alpha. From all the clones examined only DN clones 3.31 and to a lesser degree 4.19 produce IL-4. In vivo tissue localization of clones 3.8, 3.31 and 4.59 shows that these cells distribute into the liver and bone marrow 24 h post i.v. administration. Their accumulation in the liver and bone marrow along with their ability to secrete various cytokines suggest that these cells may influence the generation, differentiation or apoptosis of immune or hematopoietic cells.


Subject(s)
Antigens, Surface/physiology , Killer Cells, Natural/physiology , Lectins, C-Type , Receptors, Antigen, T-Cell, alpha-beta/physiology , T-Lymphocyte Subsets/physiology , Animals , Antigens, Surface/biosynthesis , Clone Cells , Cytokines/biosynthesis , Immunophenotyping , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Male , NK Cell Lectin-Like Receptor Subfamily B , Organ Specificity/immunology , Rats , Rats, Inbred Strains , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Immunologic/physiology , Spleen/immunology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism
18.
J Biol Chem ; 272(9): 5495-500, 1997 Feb 28.
Article in English | MEDLINE | ID: mdl-9038153

ABSTRACT

The present study examines the expression and involvement of cAMP-dependent protein kinase (PKA) isozymes in cAMP-induced inhibition of natural killer (NK) cell-mediated cytotoxicity. Rat interleukin-2-activated NK cells express the PKA alpha-isoforms RIalpha, RIIalpha, and Calpha and contain both PKA type I and type II. Prostaglandin E2, forskolin, and cAMP analogs all inhibit NK cell lysis of major histocompatibility complex class I mismatched allogeneic lymphocytes as well as of standard tumor target cells. Specific involvement of PKA in the cAMP-induced inhibition of NK cell cytotoxicity is demonstrated by the ability of a cAMP antagonist, (Rp)-8-Br-adenosine 3',5'-cyclic monophosphorothioate, to reverse the inhibitory effect of complementary cAMP agonist (Sp)-8-Br-adenosine 3',5'-cyclic monophosphorothioate. Furthermore, the use of cAMP analog pairs selective for either PKA isozyme (PKA type I or PKA type II), shows a preferential involvement of the PKA type I isozyme, indicating that PKA type I is necessary and sufficient to completely abolish killer activatory signaling leading to NK cell cytotoxicity. Finally, combined treatment with phorbol ester and ionomycin maintains NK cell cytotoxicity and eliminates the cAMP-mediated inhibition, demonstrating that protein kinase C and Ca2+-dependent events stimulate the cytolytic activity of NK cells at a site distal to the site of cAMP/PKA action.


Subject(s)
Carrier Proteins/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic AMP-Dependent Protein Kinases/pharmacology , Intracellular Signaling Peptides and Proteins , Isoenzymes/metabolism , Killer Cells, Natural/cytology , Animals , Calcium/metabolism , Cell Survival/drug effects , Cyclic AMP/pharmacology , Cyclic AMP-Dependent Protein Kinase Type II , Cytotoxicity, Immunologic/drug effects , Enzyme Activation , Interleukin-2/pharmacology , Ionomycin/pharmacology , Lymphocytes/enzymology , Lymphocytes/metabolism , Protein Kinase C/metabolism , Rats , Tetradecanoylphorbol Acetate/pharmacology , Theophylline/analogs & derivatives , Theophylline/pharmacology
19.
Immunol Rev ; 155: 91-104, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9059885

ABSTRACT

The prompt rejection of transplanted allogeneic lymphocytes by rat NK cells in non-sensitized recipients (allogeneic lymphocyte cytotoxicity or ALC) is determined by MHC genes as well as by genes located in the NK complex. The same genetic control is found when NK alloreactivity is measured by an in vitro assay, and we have employed this assay to delineate the specificity of NK cells for the MHC. The MHC of the rat, RT1, contains class I genes situated on either side of the class II/class III region. The majority of these class I genes are located in the RT1.C region and expressed class I products usually behave as non-classical (class Ib) molecules. They do not serve as restriction elements for the vast majority of conventional alpha/beta T-cells, in contrast to those class I molecules encoded by one or more loci in the classical (class Ia) region, RT1.A. However, NK cells appear to recognize the products of either class I region. Immunogenetic studies suggest that NK cells are inhibited by RT1. A molecules, whereas RT1.C region molecules may have a dual role in regulating NK cytolytic activity, i.e. they either inhibit or activate natural killing. Based on these premises, a model is proposed in which identification of a target as self or non-self depends on different receptors for class I in single NK cells, interpreting coincident positive and negative signals from the various target class I molecules. The putative role of peptides presented by class I, the biological implications, and the evolution of the NK receptors and their ligands are discussed.


Subject(s)
Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class I/metabolism , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Animals , Molecular Sequence Data , Rats
20.
Transplantation ; 63(1): 119-23, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-9000672

ABSTRACT

Major histocompatibility complex class I molecules can inhibit mouse as well as human natural killer (NK) cell cytotoxicity. In contrast, antigens encoded in the RT1.C region of the rat MHC gene complex have been suggested to trigger, rather than inhibit, rat NK cells. In an attempt to analyze rat NK cell specificity, with respect to the cross-species difference that may exist in NK cell-mediated cytotoxicity, we investigated the ability of interleukin 2-activated, allospecific rat NK cells to recognize MHC class I-positive and -deficient target cells of mouse and human origins. Recognition of xenogeneic target cells by rat allospecific NK cells was found to be MHC class I independent; target cell MHC class I was not required for killing, and expression of different sets of mouse and human MHC class I molecules did not influence the cytotoxic response. These results indicate that rat NK cells can recognize xenogeneic nontransformed cells by mechanisms not related to target cell MHC class I expression, and that mouse and human MHC class I molecules, at least among those tested in this study, are unable to confer inhibition of rat NK cells.


Subject(s)
Cytotoxicity, Immunologic , Histocompatibility Antigens Class I/physiology , Killer Cells, Natural/immunology , Animals , Haplotypes , Humans , Interleukin-2/pharmacology , Major Histocompatibility Complex , Mice , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...